Teva, three U.S. drug distributors reach opioid settlement - source

October 21, 2019 8:33 AM EDT

The logo of Teva Pharmaceutical Industries is seen during a news conference hold by its CEO, Kare Schultz, to discuss the company's 2019 outlooks in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen/File Photo

(Reuters) - Drug maker Teva Pharmaceutical Industries Inc (NYSE: TEVA) and the three biggest U.S. drug distributors reached a settlement on Monday to avoid a trial over their role in the opioid addiction crisis, a source said on Monday.

Distributors Mckesson Corp (NYSE: MCK), Cardinal Health Inc (NYSE: CAH) and AmerisourceBergen Corp (NYSE: ABC) were set to go to trial Monday morning, along with pharmacy chain Walgreen Boots Alliance Inc (NASDAQ: WBA).

The source did not say if Walgreen was part of the settlement.

(Reporting by Tom Hals in Wilmington, Delaware; editing by Jason Neely)



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

General News, Litigation, Reuters, Rumors